Table 1

Antirheumatic drug treatment in patients with any visit for rheumatoid arthritis

Drug treated (n)Drug treated (% of total RA)
Drug treatmentOverall (n=58 102)Women (n=42 152)Men (n=15 950)OverallWomenMen
Biological DMARD treatment*850865022006151513
Non-biological DMARD treatment35 85825 8669992626163
Biological or non-biological DMARD treatment37 10326 81510 288646465
Glucocorticoid treatment (ATC H02)28 69820 8947804495049
Prescription NSAIDs (ATC M01A)38 24027 98310 257666664
Any antirheumatic drug
 Excluding NSAIDs44 34732 24012 107767676
 Including NSAIDs51 65937 62814 031898988
  • * Biological DMARDs: etanercept, adalimumab, infliximab, rituximab, abatacept, anakinra (from the Swedish Biologics Register ARTIS, 1999–2007, and the Prescribed Drug Register: 2005–2007).

  • Non-biological treatment: methotrexate, sulfasalazine, leflunomide, azathioprine, antimalarial agents (ATC P01B), gold (ATC M01CB01), ciclosporin (from the Prescribed Drug Register, 2005–2007).

  • Defined as any of the drug categories above.

  • DMARD, disease-modifying antirheumatic drug; NSAID, non-steroidal anti-inflammatory drug.